{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:00:50Z","timestamp":1791320450727,"version":"4.3.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tmreviews.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.tmrv.2015.06.001","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T08:15:28Z","timestamp":1434701728000},"page":"220-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Hyperhemolysis in Patients With Hemoglobinopathies: A Single-Center Experience and Review of the Literature"],"prefix":"10.1016","volume":"29","author":[{"given":"Anicee","family":"Danaee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baba","family":"Inusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2015.06.001_bb0005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.7326\/0003-4819-93-2-231","article-title":"Delayed haemolytic transfusion reaction presenting as sickle cell crisis","volume":"93","author":"Diamond","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1423-0410.1995.tb00373.x","article-title":"Post transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction","volume":"69","author":"Cullis","year":"1995","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0015","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1537-2995.1997.37497265337.x","article-title":"Delayed haemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells","volume":"37","author":"King","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0020","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1537-2995.1997.37497265338.x","article-title":"The sickle haemolytic transfusion reaction syndrome","volume":"37","author":"Petz","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0025","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1046\/j.1537-2995.1997.371098016453.x","article-title":"The sickle haemolytic transfusion reaction syndrome","volume":"37","author":"Sirchia","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-3148.2001.00278.x","article-title":"Refractory hyperhaemolysis in a patient with beta-thalassaemia major","volume":"11","author":"Grainger","year":"2001","journal-title":"Transfus Med"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1537-2995.2001.41030323.x","article-title":"Hyperhemolytic transfusion reaction in sickle cell disease","volume":"41","author":"Win","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1537-2995.2002.00007.x","article-title":"Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions","volume":"42","author":"Aygun","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0045","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1542\/peds.111.6.e661","article-title":"Delayed haemolytic reaction\/hyperhemolysis syndrome in children with sickle cell disease","volume":"111","author":"Talano","year":"2003","journal-title":"Paediatrics"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0050","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/10245330400001926","article-title":"Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease","volume":"9","author":"Win","year":"2004","journal-title":"Hematology"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0055","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2044.2005.04188.x","article-title":"Delayed haemolytic transfusion reaction and hyperhaemolysis complicating peri-operative blood transfusion in sickle cell disease","volume":"60","author":"McGlennan","year":"2005","journal-title":"Anaesthesia"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0060","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.3324\/haematol.12074","article-title":"Rituximab for the prevention of delayed haemolytic transfusion reaction in sickle cell disease","volume":"92","author":"Noizat-Pirenne","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0065","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1537-2995.2008.01693.x","article-title":"Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review","volume":"48","author":"Win","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0070","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4038\/cmj.v53i4.283","article-title":"Hyperhaemolysis syndrome in haemoglobin E\/beta thalassaemia responding to cyclophosphomide therapy","volume":"53","author":"Senanayake","year":"2008","journal-title":"Ceylon Med J"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.21307\/immunohematology-2019-263","article-title":"Hyperhemolytic transfusion reaction attributable to anti-Fy3 in a patient with sickle cell disease","volume":"24","author":"Reyes","year":"2008","journal-title":"Immunohematology"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/0973-6247.45259","article-title":"Hyperhemolysis in a patient with \u03b2-thalassemia major","volume":"3","author":"Morawakage","year":"2009","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0085","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1600-0609.2009.01351.x","article-title":"Hyperhemolysis syndrome in a patient with sickle cell disease with erythrophagocytosis in peripheral blood","volume":"84","author":"Islam","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ajh.21578","article-title":"Rituximab as an effective treatment of hyperhaemolysis syndrome in sickle cell anaemia","volume":"85","author":"Bachmeyer","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0095","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1537-2995.2009.02399.x","article-title":"Delayed haemolytic transfusion reaction with hyperhemolysis after first red blood cell transfusion in child with \u03b2-thalassemia: challenges in treatment","volume":"50","author":"Hannema","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5694\/j.1326-5377.2010.tb03509.x","article-title":"Hyperhaemolysis in sickle cell disease\u2014an unusual and potentially life-threatening complication","volume":"192","author":"Stokes","year":"2010","journal-title":"Med J Aust"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tmrv.2009.09.006","article-title":"Treatment with intravenous immunoglobulin and steroids may correct the severe anaemia in hyperhaemolytic transfusion reaction: case report and literature review","volume":"24","author":"Win","year":"2010","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0110","doi-asserted-by":"crossref","first-page":"1062.e5","DOI":"10.1016\/j.ajem.2010.01.032","article-title":"Fatal hyperhemolytic delayed transfusion reaction in sickle cell disease: a case report and literature review","volume":"88","author":"El-Husseini","year":"2010","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/03630269.2011.649150","article-title":"Hyperhemolysis syndrome complicating pregnancy in homozygous \u03b4\u03b2-thalassemia","volume":"36","author":"Mechery","year":"2012","journal-title":"Hemoglobin"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0120","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3324\/haematol.2010.038307","article-title":"Delayed haemolytic transfusion reaction in children with sickle cell disease","volume":"96","author":"de Montalembert","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-3148.2011.01131.x","article-title":"Measurement of macrophage marker in hyperhaemolytic transfusion reaction a case report","volume":"22","author":"Win","year":"2012","journal-title":"Transfus Med"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0130","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1097\/MPH.0b013e31828e529f","article-title":"Hyperhemolysis in sickle cell disease","volume":"36","author":"Aragona","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0135","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/trf.12258","article-title":"Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion","volume":"54","author":"Uhlmann","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0140","first-page":"127","article-title":"Hyperhaemolysis syndrome responsive to splenectomy in a patient with \u03b4\u03b2-thalassaemia: a discussion on underlying mechanisms","volume":"12","author":"Vagace","year":"2014","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0145","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1097\/MPH.0000000000000241","article-title":"Severe hemolytic transfusion reaction due to anti-D in a D+ patient with sickle cell disease","volume":"37","author":"Ipe","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0150","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/tme.12131","article-title":"Hyperhaemolysis in a patient with HbH disease","volume":"24","author":"Danaee","year":"2014","journal-title":"Transfus Med"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0155","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/1024533042000205478","article-title":"Hyperhaemolysis in a patient with myelofibrosis","volume":"9","author":"Treleaven","year":"2004","journal-title":"Hematology"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0160","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/j.1537-2995.2005.00608.x","article-title":"Hyperhaemolysis syndrome in anaemia of chronic disease","volume":"45","author":"Darabi","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0165","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-3148.2011.01095.x","article-title":"Hyperhaemolysis syndrome treated with corticosteroids and darbopoietin in a patient with mantle cell lymphoma","volume":"22","author":"Babb","year":"2012","journal-title":"Transfus Med"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-3148.2011.01096.x","article-title":"A life threatening episode of treatment resistant haemolysis in a pregnant patient with dyserythropoeitic anaemia (CDA) type I","volume":"22","author":"Bank","year":"2012","journal-title":"Transfus Med"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/tme.12104","article-title":"Hyperhaemolysis in a patient with chronic lymphocytic leukaemia","volume":"24","author":"Rogers","year":"2014","journal-title":"Transfus Med"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0180","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/trf.12876","article-title":"Hyperhemolysis syndrome in a patient without hemoglobinopathy, unresponsive to treatment with eculizumab","volume":"55","author":"Gupta","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0185","first-page":"1","article-title":"Hyperhemolysis associated with marginal zone lymphoma","volume":"4","author":"Yan","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0190","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MOP.0b013e328321882e","article-title":"Current issues in blood transfusion for sickle cell disease","volume":"21","author":"Wahl","year":"2009","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0195","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V76.7.1431.1431","article-title":"Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease","volume":"76","author":"Rosse","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0200","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM199006073222301","article-title":"Alloimmunisation in sickle cell anaemia and transfusion of racially unmatched blood","volume":"322","author":"Vichinsky","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0205","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/ehm.09.2","article-title":"Hyperhaemolysis syndrome in sickle cell disease","volume":"2","author":"Win","year":"2009","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0210","series-title":"Blood transfusion in clinical medicine","first-page":"532","author":"Mollison","year":"1993"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0220","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1537-2995.1990.30891020325.x","article-title":"The differentiation of delayed serologic and delayed haemolytic transfusion reactions: incidence, long-term serologic findings and clinical significance","volume":"30","author":"Ness","year":"1990","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0225","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1537-2995.1984.24384225018.x","article-title":"Delayed haemolytic transfusion reactions; evidence for complement activation involving allogeneic and autologous red cells","volume":"24","author":"Salama","year":"1984","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0230","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1537-2995.1997.37497265334.x","article-title":"Severe reactions associated with transfusion of patients with sickle cell disease","volume":"37","author":"Garratty","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0235","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1182\/blood.V83.3.842.842","article-title":"Defective regulation of complement by the sickle erythrocyte: evidence for a defect in control of membrane attack complex function","volume":"83","author":"Test","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0240","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-2141.1997.d01-2070.x","article-title":"Presence of immunoglobulins, C3 and cytolytic C5b-9 complement components on the surface of erythrocytes from patients with beta-thalassaemia\/HbE disease","volume":"96","author":"Malasit","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0245","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1182\/blood.V88.8.3216.bloodjournal8883216","article-title":"Alloimmunization to platelets in heavily transfused patients with sickle cell disease","volume":"88","author":"Friedman","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0250","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-3148.2008.00891.x","article-title":"The James Blundell Award Lecture 2007: do we really understand immune red cell destruction?","volume":"18","author":"Garratty","year":"2008","journal-title":"Transfus Med"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0255","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1046\/j.1537-2995.2003.00381.x","article-title":"Acute and delayed haemolytic transfusion reactions secondary to HLA alloimmunization","volume":"43","author":"Benson","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0260","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1111\/j.1537-2995.2005.00607.x","article-title":"Delayed and acute haemolytic transfusion reactions resulting from red cell antibodies and red cell reactive HLA antibodies","volume":"45","author":"Takeuchi","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0265","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1751-553X.2006.00889.x","article-title":"Acute haemolytic transfusion reactions secondary to human leucocyte antigen alloimmunization","volume":"30","author":"Muro","year":"2008","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0270","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1537-2995.1979.19580059822.x","article-title":"Transfusion reaction presumably due to antiBga","volume":"19","author":"Molthan","year":"1979","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0275","first-page":"55S","article-title":"Severe symptomatic hemolytic transfusion reactions secondary to strong HLA antibody directed toward A2 public and private epitopes","volume":"33","author":"Weitkamp","year":"1993","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0280","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":"High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors","volume":"122","author":"Chou","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0285","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1046\/j.1537-2995.2002.00029.x","article-title":"DNA-based typing of blood groups for the management of multiply-transfused sickle cell disease patients","volume":"42","author":"Castilho","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0290","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/j.1537-2995.2010.02970.x","article-title":"Analysis of RhCE variants among 806 individuals in France: considerations for transfusion safety with emphasis on patients with sickle cell disease","volume":"51","author":"Pham","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2015.06.001_bb0295","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/asheducation-2009.1.178","article-title":"Molecular biology of the Rh system: clinical considerations for transfusion in sickle cell disease","author":"Chou","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796315000711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796315000711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T16:12:06Z","timestamp":1717949526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796315000711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0887796315000711"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2015.06.001","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperhemolysis in Patients With Hemoglobinopathies: A Single-Center Experience and Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2015.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}